The antagonism of amphetamine-induced symptomatology by a neuroleptic.
D000661:Amphetamine / Q000008:administration & dosage; D001923:Brain Chemistry / Q000187:drug effects; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004341:Drug Evaluation; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011569:Psychiatric Status Rating Scales; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D019966:Substance-Related Disorders
D018492:Dopamine Antagonists; D000661:Amphetamine; D006220:Haloperidol; D004298:Dopamine